←
Vergent Bioscience130 posts
Vergent Bioscience avatar

Vergent Bioscience

@VergentBio

Vergent Bioscience / @VergentBio / Tumor-targeted agents to help surgeons realize the full potential of minimally invasive and robotic-assisted cancer surgery

◷ Joined February 2015▧ 46 Photos and videos
Vergent Bioscience avatar
Vergent Bioscience@VergentBio·Oct 28

We’re pleased to welcome Paul Friel to the Vergent Bioscience Board of Directors. His experience will support Vergent as we continue to advance abenacianine and prepare for future growth. Learn more here: bit.ly/4sqKfnA

Post attachment
Vergent Bioscience avatar
Vergent Bioscience@VergentBio·Jun 9

Vergent Bioscience names Adam Gridley President & CEO. John Santini, PhD, moves to CTO to lead platform expansion as we advance a Phase 3 study evaluating abenacianine for tumor visualization during lung cancer surgery. Read more: bit.ly/43kDXu7 #Leadership

Post attachment
Vergent Bioscience avatar
Vergent Bioscience@VergentBio·6 Jan 2025

Vergent is a proud sponsor of the 5th International Sublobar Resections and Bronchoscopic Ablation Summit, taking place January 9 & 10 in #Paris. We’re looking forward to connecting with global leaders and exploring the latest in surgical #innovation.

Post attachment